Systems biology studies have gained a prominent role in understanding the interaction between adipose tissue dysfunction, insulin action, and the MetS traits and co-morbidities (that is, non-alcoholic steatohepatitis, or NASH). The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.